Atuzabrutinib (SAR 444727) is a selective Brutons tyrosine kinase (Btk) inhibitor that inhibits intra-neutrophilic neutrophilic granulocytes through inhibition of the adhesion receptor signaling pathway, and can be used to study autoimmune disorders such as arthritis in rheumatoid rodents and pemphigus vulgaris.
Molecular Weight:
539.6
Purity:
97.27%
CAS Number:
[1581714-49-9]
Formula:
C30H30FN7O2
Target:
BTK
T39056
* VAT and and shipping costs not included. Errors and price changes excepted
